Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Vasc Access ; 22(1): 34-41, 2021 Jan.
Article de Anglais | MEDLINE | ID: mdl-32406328

RÉSUMÉ

BACKGROUND: Short-term peripheral venous catheter-associated bloodstream infection rates have not been systematically studied in Asian countries, and data on peripheral venous catheter-associated bloodstream infections incidence by number of short-term peripheral venous catheter days are not available. METHODS: Prospective, surveillance study on peripheral venous catheter-associated bloodstream infections conducted from 1 September 2013 to 31 May 2019 in 262 intensive care units, members of the International Nosocomial Infection Control Consortium, from 78 hospitals in 32 cities of 8 countries in the South-East Asia Region: China, India, Malaysia, Mongolia, Nepal, Philippines, Thailand, and Vietnam. For this research, we applied definition and criteria of the CDC NHSN, methodology of the INICC, and software named INICC Surveillance Online System. RESULTS: We followed 83,295 intensive care unit patients for 369,371 bed-days and 376,492 peripheral venous catheter-days. We identified 999 peripheral venous catheter-associated bloodstream infections, amounting to a rate of 2.65/1000 peripheral venous catheter-days. Mortality in patients with peripheral venous catheter but without peripheral venous catheter-associated bloodstream infections was 4.53% and 12.21% in patients with peripheral venous catheter-associated bloodstream infections. The mean length of stay in patients with peripheral venous catheter but without peripheral venous catheter-associated bloodstream infections was 4.40 days and 7.11 days in patients with peripheral venous catheter and peripheral venous catheter-associated bloodstream infections. The microorganism profile showed 67.1% were Gram-negative bacteria: Escherichia coli (22.9%), Klebsiella spp (10.7%), Pseudomonas aeruginosa (5.3%), Enterobacter spp. (4.5%), and others (23.7%). The predominant Gram-positive bacteria were Staphylococcus aureus (11.4%). CONCLUSIONS: Infection prevention programs must be implemented to reduce the incidence of peripheral venous catheter-associated bloodstream infections.


Sujet(s)
Infections bactériennes/épidémiologie , Infections sur cathéters/épidémiologie , Cathétérisme périphérique/effets indésirables , Infection croisée/épidémiologie , Dispositifs d'accès vasculaires/effets indésirables , Asie/épidémiologie , Infections bactériennes/microbiologie , Infections bactériennes/mortalité , Infections bactériennes/thérapie , Infections sur cathéters/microbiologie , Infections sur cathéters/mortalité , Infections sur cathéters/thérapie , Cathétérisme périphérique/mortalité , Infection croisée/microbiologie , Infection croisée/mortalité , Infection croisée/thérapie , Mortalité hospitalière , Humains , Incidence , Prévention des infections , Durée du séjour , Études prospectives , Appréciation des risques , Facteurs de risque , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE